BELKIN Vision Announces FDA Clearance for the Eagle™ Device

YAVNE, ISRAEL, Dec. 12, 2023 /PRNewswire/ – [BELKIN Vision], an innovator in ophthalmic medical solutions, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device. A Q-switched, 532 nm-wavelength,…

Click here to view original post

Advertisement — Advertise with Biotech Networks